Q2 2024 |
61 |
$1.9B |
+$87.6M |
-$61.2M |
+$26.4M |
RVMD, SWTX, CYTK, MRUS, TYRA
|
13F-HR |
8/14/2024, 04:15 PM |
Q1 2024 |
59 |
$2.02B |
+$287M |
-$398M |
-$112M |
SWTX, CYTK, RVMD, TYRA, APLS
|
13F-HR |
5/15/2024, 11:20 AM |
Q4 2023 |
52 |
$2.01B |
+$115M |
-$357M |
-$242M |
MRTX, CYTK, SWTX, RVMD, APLS
|
13F-HR |
2/14/2024, 04:03 PM |
Q3 2023 |
73 |
$1.88B |
+$159M |
-$255M |
-$96.7M |
MRTX, RVMD, BGNE, TYRA, AKRO
|
13F-HR |
11/14/2023, 04:18 PM |
Q2 2023 |
79 |
$2.16B |
+$306M |
-$324M |
-$17.4M |
RETA, APLS, RVMD, TYRA, SWTX
|
13F-HR |
8/14/2023, 04:07 PM |
Q1 2023 |
75 |
$2.04B |
+$245M |
-$32.1M |
+$213M |
RXDX, RETA, BGNE, SRPT, APLS
|
13F-HR |
5/15/2023, 04:15 PM |
Q4 2022 |
71 |
$1.85B |
+$145M |
-$104M |
+$40M |
RXDX, BGNE, CYTK, RVMD, MRTX
|
13F-HR |
2/14/2023, 01:03 PM |
Q3 2022 |
73 |
$1.78B |
+$159M |
-$183M |
-$23.2M |
MRTX, CYTK, RXDX, SWTX, APLS
|
13F-HR |
11/14/2022, 04:17 PM |
Q2 2022 |
76 |
$1.58B |
+$45.2M |
-$57.7M |
-$12.5M |
MRTX, CYTK, BGNE, RVMD, APLS
|
13F-HR |
8/15/2022, 04:37 PM |
Q1 2022 |
74 |
$1.95B |
+$279M |
-$187M |
+$92.5M |
MRTX, SWTX, ITOS, BGNE, RVMD
|
13F-HR |
5/16/2022, 04:15 PM |
Q4 2021 |
70 |
$2.51B |
+$383M |
-$530M |
-$146M |
MRTX, XBI, ITOS, BGNE, SWTX
|
13F-HR |
2/14/2022, 04:05 PM |
Q3 2021 |
87 |
$2.86B |
+$448M |
-$306M |
+$142M |
MRTX, BGNE, SWTX, ITOS, TYRA
|
13F-HR |
11/15/2021, 04:31 PM |
Q2 2021 |
95 |
$2.83B |
+$214M |
-$8.1M |
+$205M |
MRTX, BGNE, SWTX, ITOS, RVMD
|
13F-HR |
8/16/2021, 04:16 PM |
Q1 2021 |
85 |
$2.91B |
+$372M |
-$308M |
+$64.1M |
MRTX, BGNE, RVMD, SWTX, ITOS
|
13F-HR |
5/17/2021, 04:15 PM |
Q4 2020 |
78 |
$3.1B |
+$428M |
-$659M |
-$232M |
MRTX, BGNE, SWTX, ITOS, PMVP
|
13F-HR |
2/16/2021, 04:31 PM |
Q3 2020 |
75 |
$2.89B |
+$640M |
-$310M |
+$330M |
IMMU, BGNE, MRTX, RVMD, ITOS
|
Restatement |
11/17/2020, 01:46 PM |
Q2 2020 |
65 |
$2.27B |
+$237M |
-$196M |
+$40.6M |
IMMU, MRTX, BGNE, ODTC, RVMD
|
13F-HR |
8/14/2020, 04:32 PM |
Q1 2020 |
61 |
$1.45B |
+$388M |
-$197M |
+$191M |
MRTX, IMMU, BGNE, ODTC, RVMD
|
13F-HR |
5/15/2020, 04:25 PM |
Q4 2019 |
50 |
$1.72B |
+$305M |
-$380M |
-$75.3M |
MRTX, IMMU, BGNE, ODTC, MDCO
|
13F-HR |
2/14/2020, 04:30 PM |
Q3 2019 |
48 |
$1.37B |
+$394M |
-$637K |
+$394M |
ONCE, MRTX, BGNE, IMMU, ODTC
|
13F-HR |
11/14/2019, 05:22 PM |
Q2 2019 |
0 |
$0 |
$0 |
$0 |
|
|
New Holdings |
8/15/2019, 04:40 PM |
Q2 2019 |
35 |
$1.14B |
+$300M |
-$87.5M |
+$213M |
MRTX, ODTC, BGNE, IMMU, ONCE
|
13F-HR |
8/14/2019, 04:30 PM |
Q1 2019 |
23 |
$865M |
+$203M |
-$223M |
-$19.5M |
MRTX, BGNE, IMMU, ODTC, QURE
|
13F-HR |
5/15/2019, 04:02 PM |
Q4 2018 |
23 |
$805M |
+$225M |
-$92.9M |
+$132M |
BGNE, SLDB, PTCT, WVE, MRTX
|
13F-HR |
2/14/2019, 04:26 PM |
Q3 2018 |
24 |
$897M |
+$66.7M |
-$158M |
-$91.2M |
SLDB, BGNE, PTCT, WVE, MRTX
|
13F-HR |
11/14/2018, 04:16 PM |
Q2 2018 |
26 |
$883M |
+$224M |
-$307M |
-$83.4M |
SLDB, BGNE, MRTX, PTCT, ODTC
|
13F-HR |
8/14/2018, 05:23 PM |
Q1 2018 |
32 |
$935M |
+$293M |
-$26.1M |
+$266M |
AVXS, BGNE, PTCT, ESPR, ODTC
|
13F-HR |
5/15/2018, 04:02 PM |
Q4 2017 |
26 |
$547M |
+$177M |
-$84.1M |
+$92.6M |
AVXS, ODTC, BGNE, ESPR, MGNX
|
13F-HR |
2/14/2018, 04:54 PM |
Q3 2017 |
30 |
$439M |
+$39.3M |
-$73.9M |
-$34.5M |
AVXS, BGNE, CLVSQ, MGNX, MDCO
|
13F-HR |
11/14/2017, 04:10 PM |
Q2 2017 |
26 |
$400M |
+$60.5M |
-$150M |
-$89.8M |
AVXS, CLVSQ, ESPR, MDCO, MGNX
|
13F-HR |
8/14/2017, 04:32 PM |
Q1 2017 |
30 |
$424M |
+$106M |
-$7.72M |
+$98M |
AVXS, CLVSQ, MDCO, ESPR, BGNE
|
13F-HR |
5/15/2017, 05:01 PM |
Q4 2016 |
27 |
$237M |
+$74.3M |
-$40.4M |
+$33.9M |
AVXS, CLVSQ, MDCO, BGNE, BPMC
|
13F-HR |
2/14/2017, 05:07 PM |
Q3 2016 |
27 |
$202M |
+$70.8M |
-$13.5M |
+$57.3M |
CLVSQ, MDCO, BPMC, BGNE, SGEN
|
13F-HR |
11/14/2016, 04:51 PM |
Q2 2016 |
23 |
$106M |
+$28.9M |
-$13.8M |
+$15.1M |
BGNE, BPMC, SGEN, INCY, REGN
|
13F-HR |
8/15/2016, 04:46 PM |
Q1 2016 |
22 |
$102M |
+$51.6M |
-$30.4M |
+$21.3M |
MRTX, BPMC, BGNE, CPXX, SGEN
|
13F-HR |
5/16/2016, 04:30 PM |
Q4 2015 |
15 |
$116M |
$0 |
$0 |
|
MRTX, AQXP, BPMC, SGEN, KURA
|
13F-HR |
2/16/2016, 04:30 PM |